Sundar.M
☆    

India,
2019-02-15 14:37
(2680 d 03:12 ago)

Posting: # 19925
Views: 3,266
 

 Dose curve [PK / PD]

Post reply
Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN
 
UA Flag
Activity
 Admin contact
23,654 posts in 4,992 threads, 1,570 registered users;
176 visitors (0 registered, 176 guests [including 26 identified bots]).
Forum time: 18:50 CEST (Europe/Vienna)

“Data! Data! Data!” he cried impatiently.
“I can’t make bricks without clay!”    Arthur Conan Doyle

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5